Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Fosun Pharma Rumored to Offer $480 Million for Lumenis of Israel

publication date: Feb 19, 2015
Shanghai Fosun Pharma is rumored to be in talks to acquire Lumenis Ltd., an Israeli medical device company. Fosun is reportedly willing to pay $480 million for Lumenis, which makes laser, pulsed light and RF frequency devices for aesthetic uses as well as other minimally invasive procedures. In 2013, Fosun paid $240 million for another Israeli aesthetic device company, Alma Lasers. According to reports, Fosun plans to merge the two companies into one. More details....

Stock Symbols: (SHA: 600196; HK: 02196) (NSDQ: LMNS)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital